318 related articles for article (PubMed ID: 23633090)
1. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.
Strang J; Bird SM; Parmar MK
J Urban Health; 2013 Oct; 90(5):983-96. PubMed ID: 23633090
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
Parmar MK; Strang J; Choo L; Meade AM; Bird SM
Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
[TBL] [Abstract][Full Text] [Related]
3. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.
Strang J
Addiction; 2015 Jul; 110 Suppl 2():27-35. PubMed ID: 26042565
[TBL] [Abstract][Full Text] [Related]
4. Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trial.
Meade AM; Bird SM; Strang J; Pepple T; Nichols LL; Mascarenhas M; Choo L; Parmar MKB
Drug Alcohol Rev; 2018 May; 37(4):487-498. PubMed ID: 28940805
[TBL] [Abstract][Full Text] [Related]
5. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
[TBL] [Abstract][Full Text] [Related]
6. Take-home emergency naloxone to prevent deaths from heroin overdose.
Strang J; Bird SM; Dietze P; Gerra G; McLellan AT
BMJ; 2014 Nov; 349():g6580. PubMed ID: 25378248
[No Abstract] [Full Text] [Related]
7. 'I saved a life': a heroin addict's reflections on managing an overdose using 'take home naloxone'.
George S; Boulay S; Begley D
BMJ Case Rep; 2010 Sep; 2010():. PubMed ID: 22778195
[TBL] [Abstract][Full Text] [Related]
8. Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact.
Strang J
Eur Addict Res; 2022; 28(3):161-175. PubMed ID: 34963112
[TBL] [Abstract][Full Text] [Related]
9. [First Aid Training for Drug Overdose in Opioid Addicts and Provision of Take-Home Naloxone on Release from Prison: Feasibility Study from the Bavarian Model Project].
Wodarz-von Essen HJ; Wolstein J; Pogarell O; Wodarz N
Gesundheitswesen; 2023 Jun; 85(6):568-572. PubMed ID: 36126950
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
[TBL] [Abstract][Full Text] [Related]
11. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
Seal KH; Downing M; Kral AH; Singleton-Banks S; Hammond JP; Lorvick J; Ciccarone D; Edlin BR
J Urban Health; 2003 Jun; 80(2):291-301. PubMed ID: 12791805
[TBL] [Abstract][Full Text] [Related]
12. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
[TBL] [Abstract][Full Text] [Related]
13. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
Winston I; McDonald R; Tas B; Strang J
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
[TBL] [Abstract][Full Text] [Related]
15. Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.
Strang J; McDonald R; Campbell G; Degenhardt L; Nielsen S; Ritter A; Dale O
Drugs; 2019 Sep; 79(13):1395-1418. PubMed ID: 31352603
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia.
Moradmand-Badie B; Tran L; Oikarainen N; Degenhardt L; Nielsen S; Roberts J; Ward S; Bowman J; Larney S
Drug Alcohol Rev; 2021 Jan; 40(1):98-108. PubMed ID: 32808357
[TBL] [Abstract][Full Text] [Related]
17. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
[TBL] [Abstract][Full Text] [Related]
18. Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: a preliminary study.
Petterson AG; Madah-Amiri D
Harm Reduct J; 2017 Nov; 14(1):74. PubMed ID: 29162122
[TBL] [Abstract][Full Text] [Related]
19. Two cases of intranasal naloxone self-administration in opioid overdose.
Green TC; Ray M; Bowman SE; McKenzie M; Rich JD
Subst Abus; 2014; 35(2):129-32. PubMed ID: 24821348
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities.
Coffin PO; Sullivan SD
J Med Econ; 2013 Aug; 16(8):1051-60. PubMed ID: 23730942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
